[Management in exposure to possibly infectious blood via the skin or mucous membranes].
Leentvaar-Kuijpers
A
A
Coutinho
R A
RA
D000914:Antibodies, Viral / Q000032:analysis; D002985:Clinical Protocols; D003428:Cross Infection / Q000517:prevention & control*; D015483:HIV Antibodies; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D009339:Needles; D014950:Wounds, Penetrating / Q000150:complications*
D000914:Antibodies, Viral; D015483:HIV Antibodies; D006514:Hepatitis B Surface Antigens
Het beleid bij blootstelling aan mogelijk infectieus bloed via huid of slijmvliezen.